Holders over time
- KRYS
- AMGN
| Quarter | KRYS | AMGN |
|---|---|---|
| Q3 2020 | 4 holders, $52m | 16 holders, $16.3bn |
| Q4 2020 | 3 holders, $66m | 19 holders, $14.0bn |
| Q1 2021 | 3 holders, $67m | 16 holders, $14.5bn |
| Q2 2021 | 2 holders, $28m | 23 holders, $13.8bn |
| Q3 2021 | 2 holders, $31m | 24 holders, $11.6bn |
| Q4 2021 | 2 holders, $135m | 21 holders, $10.4bn |
| Q1 2022 | 1 holders, $114m | 23 holders, $9.9bn |
| Q2 2022 | 2 holders, $107m | 28 holders, $9.7bn |
| Q3 2022 | 3 holders, $97m | 21 holders, $7.9bn |
| Q4 2022 | 3 holders, $59m | 24 holders, $9.3bn |
| Q1 2023 | 3 holders, $59m | 22 holders, $8.4bn |
| Q2 2023 | 3 holders, $82m | 26 holders, $7.4bn |
| Q3 2023 | 5 holders, $143m | 26 holders, $8.7bn |
| Q4 2023 | 5 holders, $109m | 24 holders, $8.4bn |
| Q1 2024 | 8 holders, $853m | 25 holders, $6.7bn |
| Q2 2024 | 6 holders, $1.0bn | 20 holders, $8.0bn |
| Q3 2024 | 5 holders, $976m | 21 holders, $8.8bn |
| Q4 2024 | 5 holders, $850m | 20 holders, $8.2bn |
| Q1 2025 | 5 holders, $993m | 25 holders, $12.0bn |
| Q2 2025 | 4 holders, $746m | 20 holders, $10.2bn |
| Q3 2025 | 5 holders, $938m | 17 holders, $10.4bn |
| Q4 2025 | 7 holders, $1.4bn | 19 holders, $18.0bn |
| Q1 2026 | 6 holders, $1.5bn | 15 holders, $21.4bn |
| Q2 2026 | 6 holders, $2.4bn | 23 holders, $24.9bn |
Krystal Biotech Inc
- Holders
- 6
- Reported value
- $2.4bn
- Buyers
- 12
- Sellers
- 14
Breadth -2 among 91 comparable managers.
Amgen Inc
- Holders
- 23
- Reported value
- $24.9bn
- Buyers
- 19
- Sellers
- 13
Breadth +6 among 91 comparable managers.
Who holds both, Q2 2026
Both (6)
Bridgewater Associates LP, Capital World Investors, Fidelity (FMR LLC), Janus Henderson Group Ltd, T. Rowe Price Associates Inc, Woodline Partners LP
Only KRYS (0)
None.
Only AMGN (17)
AllianceBernstein LP, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Capital Research Global Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Marshall Wace LLP, Neuberger Berman Group LLC, PDT Partners LLC, Squarepoint Ops LLC, Two Sigma Investments LP, Walleye Capital LLC, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.